BBEdit 13.0.5 for mac是Mac上领先的专业HTML和文本编辑器。这款屡获殊荣的产品是专门为响应Web作者和软件开发人员的需求而设计的，它提供了用于编辑，搜索和操纵文本的众多功能。BBEdit可以高效转换文本。. BBEdit 13.5 is a feature update, which includes notable new features, visible changes to existing features, and fixes for reported issues. Because BBEdit 13.5 builds on features that were added in BBEdit 13.0 and 13.1, please take a few moments to review the release notes for BBEdit 13.0 and BBEdit 13.1, as well as their (respective) updates.
最新バージョン: 13.0.3
定格 4.5/5 によって 15 人々
BBEdit は何をしますか? BBEdit is the leading professional text, code, and markup editor for the Macintosh. https://bestpfil246.weebly.com/master-pdf-editor-3-3-20-download-free.html. As the 'go to' tool for web site designers, web application developers, writers, and software developers, this award-winning product provides an abundance of high-performance features for editing, searching, and manipulation of text, code, and HTML/XML markup.As a replacement for TextWrangler, BBEdit is built by the same developers, using the same award-winning technology, and is identical to TextWrangler in every way you're used to. BBEdit is 64-bit and compatible with macOS Catalina.An intelligent interface provides easy access to BBEdit’s best-of-class features, including: grep pattern matching; search and replace across multiple files; project definition tools; function navigation and syntax coloring for numerous source code languages; code folding; FTP and SFTP open and save; AppleScript and Automator support; Unix scripting support; text and code completion; a complete set of robust HTML tools; and more.BBEdit offers a 30-day evaluation period (beginning the first time you use it on your computer), during which its full feature set is available.During the evaluation period, BBEdit is fully functional. After the evaluation period has expired, you can continue to use BBEdit for free, forever, with no nag screens or unsolicited interruptions.In “free mode”, BBEdit provides a modified set of features, which incorporates a powerful set of core features. Using BBEdit in free mode costs you nothing, while providing an upgrade path to advanced features and capabilities.To enable BBEdit’s advanced features after the evaluation period is over, you will need to have an active BBEdit subscription. Subscriptions are available on either a monthly or annual basis.An active subscription gives you access to all of BBEdit’s advanced features, including any new features that we introduce during updates or major upgrades, for as long as the subscription is in good standing.Please see our comparison chart for a detailed listing of which advanced features are available with a subscription.Subscription terms and conditions:We do not collect any data from your use of BBEdit, whether or not a subscription is in effect.Your interactions with BBEdit and with Bare Bones Software, Inc. are protected by our privacy policy.Your use of BBEdit is governed by the terms of its end-user license.When you purchase a subscription, payment will be charged to your iTunes Account upon confirmation of purchase.Your subscription will renew automatically, unless you cancel your subscription at least 24 hours prior to the end of the currently active subscription period. Your iTunes Account will be charged for the renewal within 24 hours prior to the end of the currently active subscription period, and your account history will reflect the cost of the renewal.You can manage your subscription and cancel automatic renewal by going to your 'Manage my Subscriptions' page after purchase.Purchasing a subscription will permanently end your evaluation period, and forfeits any unused portion of the evaluation period, if applicable.For the full text of the BBEdit end user license for Mac App Store customers, please visit this page on our web site: https://www.barebones.com/products/bbedit/appstore/terms.html
MacOS 用にダウンロード - サーバー 1 --> 無料Latest update - 12 October 2020
COVID-19 is the infectious disease caused by the coronavirus, SARS-CoV-2, which is a respiratory pathogen. WHO first learned of this new virus from cases in Wuhan, People’s Republic of China on 31 December 2019.
The most common symptoms of COVID-19 are
Vectoraster 7 1 6 download free. Other symptoms that are less common and may affect some patients include: Name of the company that owns bricsys.
Symptoms are usually mild. Some people become infected but only have very mild symptoms or none at all.
Symptoms of severe COVID‐19 disease include:
Other less common symptoms are:
People of all ages who experience fever and/or cough associated with difficulty breathing or shortness of breath, chest pain or pressure, or loss of speech or movement should seek medical care immediately. If possible, call your health care provider, hotline or health facility first, so you can be directed to the right clinic.
Most people (about 80%) recover from the disease without needing hospital treatment. About 20% of those who get COVID-19 become seriously ill and require oxygen, with 5% becoming critically ill and needing intensive care.
Complications leading to death may include respiratory failure, acute respiratory distress syndrome (ARDS), sepsis and septic shock, thromboembolism, and/or multiorgan failure, including injury of the heart, liver or kidneys.
In rare situations, children can develop a severe inflammatory syndrome a few weeks after infection.
People aged 60 and over, and those with underlying medical problems like high blood pressure, heart and lung problems, diabetes, obesity or cancer, are at higher risk of developing serious illness.
However, anyone can get sick with COVID-19 and become seriously ill or die at any age.
Stay safe by taking some simple precautions, such as physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning your hands, and coughing into a bent elbow or tissue. Check local advice where you live and work. Do it all!
Read our public advice page for more information.
Anyone with symptoms should be tested, wherever possible. People who do not have symptoms but have had close contact with someone who is, or may be, infected may also consider testing – check with your local health guidelines. While a person is waiting for test results, they should remain isolated from others. Where testing capacity is limited, tests should first be done for those at higher risk of infection, such as health workers, and those at higher risk of severe illness such as older people, especially those living in seniors’ residences or long-term care facilities.
In most situations, a molecular test is used to detect SARS-CoV-2 and confirm COVID-19. Polymerase chain reaction (PCR) is the most commonly used molecular test. Samples are collected from the nose and/or throat with a swab. Molecular tests detect virus in the sample by amplifying viral genetic material to detectable levels. For this reason, a molecular test is used to confirm an active infection, usually within a few days of exposure and around the time that symptoms may begin.
Rapid tests (sometimes known as a rapid diagnostic test – RDT) detect viral proteins (known as antigens). Samples are collected from the nose and/or throat with a swab. These tests are cheaper than PCR and will offer results more quickly, although they are generally less accurate. We are still learning about how well they perform and when to use them.
Antibody tests can tell us whether someone has had an infection in the past, even if they have not had symptoms. Also known as serological tests and usually done on a blood sample, these tests detect antibodies produced in response to an infection. In most people, antibodies start to develop after days to weeks and can indicate if a person has had recent (IgM type antibodies) or past infection (IgG type). Antibody tests cannot be used to diagnose COVID-19 in the early stages of infection or disease. They also cannot alone confirm immunity or duration of protection from reinfection.
Both isolation and quarantine are methods of preventing the spread of the disease. Permute 3 v3 1 3.
Quarantine means restricting activities and/or separating people who are not ill but may have been exposed to COVID-19. The quarantine can take place in a designated facility or at home for 14 days.
Isolation means separating people who are ill with symptoms of COVID-19 and/or have tested positive.
If you have been exposed to someone with COVID-19, you may become infected, even if you feel well.
After exposure to someone who has COVID-19, do the following:
If you live in an area with malaria or dengue fever, seek medical help if you have a fever. While travelling to and from the health facility and during medical care, wear a mask, keep at least a 1-metre distance from other people and avoid touching surfaces with your hands. This applies to adults and children.
Read our malaria and COVID-19 Q&A for more information.
The time from exposure to COVID-19 to the moment when symptoms begin is, on average, 5-6 days and can range from 1-14 days. This is why people who have been exposed to the virus are advised to stay home, apart from others, for 14 days, in order to prevent the spread of the virus, especially where testing is not easily available.
If you have any symptoms suggestive of COVID-19, contact your health care provider or COVID-19 hotline for instructions and find out when and where to get a test, stay at home for 14 days away from others and monitor your health.
If you have shortness of breath or pain or pressure in the chest, seek medical attention immediately. Call your health care provider or hotline in advance for direction to the right health facility.
If you live in an area with malaria or dengue fever, seek medical care if you have a fever.
If local guidance recommends visiting a medical centre for testing, assessment or isolation, wear a medical mask while travelling to and from the facility and during medical care. Also keep at least a 1-metre distance from other people and avoid touching surfaces with your hands. This applies to adults and children.
Not yet. Many potential vaccines for COVID-19 are being studied, and several large clinical trials may report results later this year. If a vaccine is proven safe and effective, it must be approved by national regulators, manufactured, and distributed. WHO is working with partners around the world to help coordinate key steps in this process. WHO is working through the ACT-Accelerator to facilitate equitable access to a safe and effective vaccine for the billions of people who will need it, once it is available. More information about COVID-19 vaccine development is available here.
Scientists around the world are working to find and develop treatments for COVID-19.
Optimal supportive care includes oxygen for severely ill patients and those who are at risk for severe disease and more advanced respiratory support such as ventilation for patients who are critically ill.
Dexamethasone is a corticosteroid that can help reduce the length of time on a ventilator and save lives of patients with severe and critical illness. Read our dexamethasone Q&A for more information.
Results from the WHO’s Solidarity Trial indicated that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.
Hydroxychloroquine has not been shown to offer any benefit for treatment of COVID-19. Read our hydroxychloroquine Q&A for more information.
WHO does not recommend self-medication with any medicines, including antibiotics, as a prevention or cure for COVID-19. WHO is coordinating efforts to develop treatments for COVID-19 and will continue to provide new information as it becomes available.
Antibiotics do not work against viruses; they only work on bacterial infections. COVID-19 is caused by a virus, so antibiotics do not work. Antibiotics should not be used as a means of prevention or treatment of COVID-19.
In hospitals, physicians will sometimes use antibiotics to prevent or treat secondary bacterial infections which can be a complication of COVID-19 in severely ill patients. They should only be used as directed by a physician to treat a bacterial infection.
Related
More
0 
Star